Skip to main content
Premium Trial:

Request an Annual Quote

Empire Genomics Nabs $1.8M Investment

NEW YORK (GenomeWeb) – Empire Genomics has closed a $1.75 million follow-on financing round, the company and investor Rand Capital said yesterday.

The new financing was led by existing investor BroadOak Capital Partners and included a $250,000 investment from Rand Capital, bringing its total investment in Empire to $1.15 million.

Buffalo, NY-based Empire Genomics is a 2006 spinout from the Roswell Park Cancer Institute that develops molecular diagnostic products and provides assay-development services. The company said it will use the proceeds of the recent financing to grow its marketing, automation, and operations, and to launch additional molecular diagnostic products.

"We intend to make additional investments in the talent and infrastructure needed to advance our work and build scale to support the further commercialization of our products," Anthony Johnson, president and CEO of Empire Genomics, said in a statement. "Our business continues to gain momentum, with first quarter revenue up almost 50 percent over last year's first quarter."

Johnson also noted that the firm recently inked an exclusive agreement with an unnamed distributor for its products in China.

In May, Empire Genomics received approval from New York State to offer molecular and cellular tumor marker testing through the state's Clinical Laboratory Evaluation Program.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.